Renovaro Biosciences Stock Market Value
| RENB Stock | 0.61 0.09 17.31% |
| Symbol | Renovaro |
Renovaro Biosciences Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Renovaro Biosciences. If investors know Renovaro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Renovaro Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.98) | Return On Assets (0.15) | Return On Equity (0.90) |
The market value of Renovaro Biosciences is measured differently than its book value, which is the value of Renovaro that is recorded on the company's balance sheet. Investors also form their own opinion of Renovaro Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Renovaro Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Renovaro Biosciences' market value can be influenced by many factors that don't directly affect Renovaro Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Renovaro Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Renovaro Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Renovaro Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Renovaro Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Renovaro Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Renovaro Biosciences.
| 10/30/2024 |
| 11/29/2024 |
If you would invest 0.00 in Renovaro Biosciences on October 30, 2024 and sell it all today you would earn a total of 0.00 from holding Renovaro Biosciences or generate 0.0% return on investment in Renovaro Biosciences over 30 days. Renovaro Biosciences is related to or competes with Xponential Fitness, Oatly Group, Compania Cervecerias, Boston Beer, Reservoir Media, Constellation Brands, and Playtika Holding. Renovaro Biosciences is entity of United States More
Renovaro Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Renovaro Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Renovaro Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 8.01 | |||
| Information Ratio | 0.0131 | |||
| Maximum Drawdown | 51.42 | |||
| Value At Risk | (13.24) | |||
| Potential Upside | 17.31 |
Renovaro Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Renovaro Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Renovaro Biosciences' standard deviation. In reality, there are many statistical measures that can use Renovaro Biosciences historical prices to predict the future Renovaro Biosciences' volatility.| Risk Adjusted Performance | 0.0292 | |||
| Jensen Alpha | 0.0749 | |||
| Total Risk Alpha | (1.21) | |||
| Sortino Ratio | 0.0157 | |||
| Treynor Ratio | 0.1673 |
Renovaro Biosciences Backtested Returns
Renovaro Biosciences appears to be out of control, given 3 months investment horizon. Renovaro Biosciences maintains Sharpe Ratio (i.e., Efficiency) of 0.0715, which implies the firm had a 0.0715% return per unit of risk over the last 3 months. By analyzing Renovaro Biosciences' technical indicators, you can evaluate if the expected return of 0.69% is justified by implied risk. Please evaluate Renovaro Biosciences' Coefficient Of Variation of 3838.11, risk adjusted performance of 0.0292, and Semi Deviation of 7.36 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Renovaro Biosciences holds a performance score of 5. The company holds a Beta of 1.44, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Renovaro Biosciences will likely underperform. Please check Renovaro Biosciences' expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to make a quick decision on whether Renovaro Biosciences' historical price patterns will revert.
Auto-correlation | 0.06 |
Virtually no predictability
Renovaro Biosciences has virtually no predictability. Overlapping area represents the amount of predictability between Renovaro Biosciences time series from 30th of October 2024 to 14th of November 2024 and 14th of November 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Renovaro Biosciences price movement. The serial correlation of 0.06 indicates that barely 6.0% of current Renovaro Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.06 | |
| Spearman Rank Test | 0.72 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Renovaro Biosciences lagged returns against current returns
Autocorrelation, which is Renovaro Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Renovaro Biosciences' stock expected returns. We can calculate the autocorrelation of Renovaro Biosciences returns to help us make a trade decision. For example, suppose you find that Renovaro Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Renovaro Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Renovaro Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Renovaro Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Renovaro Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Renovaro Biosciences Lagged Returns
When evaluating Renovaro Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Renovaro Biosciences stock have on its future price. Renovaro Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Renovaro Biosciences autocorrelation shows the relationship between Renovaro Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Renovaro Biosciences.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Renovaro Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Renovaro Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Renovaro Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Renovaro Biosciences Stock:Check out Renovaro Biosciences Correlation, Renovaro Biosciences Volatility and Renovaro Biosciences Alpha and Beta module to complement your research on Renovaro Biosciences. For information on how to trade Renovaro Stock refer to our How to Trade Renovaro Stock guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Renovaro Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.